نتائج البحث - "Muscarinic antagonist"

1

When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

المؤلفون: Wen-Chien Cheng, Wu-Huei Hsu, Chih-Yu Chen, Biing-Ru Wu, Wei Chun Chen, Chia-Hung Chen, Chih Yen Tu, Te Chun Hsia, Wei-Chih Liao

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: long-acting β2 agonist, medicine.medical_specialty, Multivariate analysis, medicine.drug_class, LABA, Muscarinic Antagonists, Disease, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, CID, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, Administration, Inhalation, long-acting muscarinic antagonist, COPD, Humans, Medicine, 030212 general & internal medicine, chronic pulmonary obstructive disease, Adrenergic beta-2 Receptor Agonists, Original Research, clinically important deterioration, Retrospective Studies, biology, Receiver operating characteristic, business.industry, LAMA, Muscarinic antagonist, General Medicine, Lama, biology.organism_classification, medicine.disease, Bronchodilator Agents, 030228 respiratory system, ICS, triple therapy, Ics laba, Disease Progression, Corticosteroid, Drug Therapy, Combination, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40d1c3a1c43ae6a1bb67ff4d5df786a6Test
https://doi.org/10.2147Test/copd.s279482

2

Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations

المؤلفون: Eva Topole, Nicola Scichilone, Dennis Belmans, Roberta De Maria, Omar S. Usmani, Jan De Backer, George Georges, Cedric Van Holsbeke, Erika Cuoghi, Benjamin Mignot

المساهمون: Usmani O.S., Scichilone N., Mignot B., Belmans D., Van Holsbeke C., De Backer J., De Maria R., Cuoghi E., Topole E., Georges G.

المصدر: International Journal of COPD, Vol Volume 15, Pp 2433-2440 (2020)
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Respiratory System, Urology, International Journal of Chronic Obstructive Pulmonary Disease, Settore MED/10 - Malattie Dell'Apparato Respiratorio, tomography, Dry powder inhalers, Inhaled corticosteroid, Long-acting beta2 agonist, Long-acting muscarinic antagonist, Metered dose inhalers, Tomography, X-ray computed, inhaled corticosteroid, Fluticasone propionate, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, Formoterol Fumarate, Bronchodilator, Administration, Inhalation, medicine, Humans, long-acting muscarinic antagonist, Computer Simulation, Glycopyrronium bromide, Respiratory system, metered dose inhalers, 1102 Cardiorespiratory Medicine and Haematology, Original Research, x-ray computed, lcsh:RC705-779, COPD, Science & Technology, Inhalation, business.industry, dry powder inhalers, General Medicine, lcsh:Diseases of the respiratory system, respiratory system, medicine.disease, Bronchodilator Agents, Drug Combinations, chemistry, Corticosteroid, Vilanterol, business, Life Sciences & Biomedicine, long-acting beta2 agonist, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8174ff3834f84485bb536ddecb96cbdTest
https://www.dovepress.com/airway-deposition-of-extrafine-inhaled-triple-therapy-in-patients-with-peer-reviewed-articleTest-COPD

3

Medium-dose ICS-containing FDCs reduce all-cause mortality in COPD patients: an in-depth analysis of dual and triple therapies

المؤلفون: Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani, Beatrice Ludovica Ritondo, Alfredo Chetta

المساهمون: Calzetta, L., Ritondo, B. L., Matera, M. G., Chetta, A., Rogliani, P.

المصدر: Expert Review of Respiratory Medicine. 16:357-365

مصطلحات موضوعية: Adrenergic beta-2 Receptor Agonist, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Copd patients, LABA, Muscarinic Antagonists, Pulmonary Disease, Chronic Obstructive, Administration, Inhalation, Settore MED/10, medicine, COPD, Humans, Immunology and Allergy, Intensive care medicine, network meta-analysis, Adrenergic beta-2 Receptor Agonists, Bronchodilator Agent, biology, business.industry, Nebulizers and Vaporizers, LAMA, Public Health, Environmental and Occupational Health, DUAL (cognitive architecture), Lama, biology.organism_classification, medicine.disease, mortality, Bronchodilator Agents, network meta-analysi, Muscarinic Antagonist, ICS, triple therapy, Vital Status, business, Nebulizers and Vaporizer, hormones, hormone substitutes, and hormone antagonists, All cause mortality, Human

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae2344cf1570e66b6b426d758d298a2Test
https://doi.org/10.1080/17476348.2021.1951237Test

4

A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand

المؤلفون: Raewyn J Scott, Tim Holbrook, Brett Marett, Robert P. Young, Dominique Milea, Anthony Braganza, Barry Gribben, Xiaomeng Xu, Aldo Amador Navarro Rojas

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, long-acting β-agonist, Treatment duration, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, chronic obstructive pulmonary disease, Persistence (computer science), Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, multiple-inhaler triple therapy, Internal medicine, Bronchodilator, Administration, Inhalation, Humans, long-acting muscarinic antagonist, Medicine, 030212 general & internal medicine, Medical prescription, Adrenergic beta-2 Receptor Agonists, Aged, Retrospective Studies, Original Research, COPD, business.industry, Nebulizers and Vaporizers, Inhaler, Mean age, General Medicine, medicine.disease, Bronchodilator Agents, 030228 respiratory system, Corticosteroid, Drug Therapy, Combination, business, New Zealand

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a5fba999363668a6349da1d05c016efTest
https://doi.org/10.2147Test/copd.s295183

5

Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study

المؤلفون: Gary T. Ferguson, Kimberly Rossman, Dave Singh, Roopa Trivedi, Earl St Rose, Shaila Ballal, Paul Dorinsky, Fernando J. Martinez, Magnus Aurivillius, Patrick Darken, Colin Reisner, Klaus F. Rabe, Jadwiga A. Wedzicha, Chen Wang

المصدر: American Journal of Respiratory and Critical Care Medicine

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Budesonide, medicine.medical_specialty, Chronic Obstructive Pulmonary Disease, Pulmonary disease, urologic and male genital diseases, Critical Care and Intensive Care Medicine, Pulmonary Disease, Chronic Obstructive, Double-Blind Method, Adrenal Cortex Hormones, Internal medicine, Formoterol Fumarate, medicine, Humans, Glycopyrrolate, COPD, Group study, business.industry, Original Articles, medicine.disease, BGF metered-dose inhaler, mortality, Obstructive lung disease, respiratory tract diseases, inhaled corticosteroids/long-acting muscarinic antagonist/long-acting β2-agonist, triple therapy, Formoterol, business, All cause mortality, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a1058cbdb73d18dbf60fe345e32e86aTest
http://europepmc.org/articles/PMC7924571Test

6

Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers

المؤلفون: Jessica Franchino-Elder, Ami R Buikema, David Singer, Caitlin A Elliott, Lindsay G S Bengtson

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Medicare, Patient Readmission, chronic obstructive pulmonary disease, soft mist inhaler, readmissions, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, dry powder inhaler, exacerbations, Internal medicine, Administration, Inhalation, medicine, COPD, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Adrenergic beta-2 Receptor Agonists, Asthma, Original Research, healthcare resource utilization, Aged, SMI, business.industry, Inhaler, LAMA, Dry Powder Inhalers, General Medicine, Odds ratio, medicine.disease, Confidence interval, Dry-powder inhaler, United States, Discontinuation, Bronchodilator Agents, DPI, 030228 respiratory system, Cohort, Disease Progression, Female, business, Delivery of Health Care

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5802e00c24becf505175d25f83402e14Test
http://europepmc.org/articles/PMC7732756Test

7

First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Naïve Chronic Obstructive Pulmonary Disease

المؤلفون: Makoto Yoshida, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Ayako Takamori, Shinichiro Hayashi, Hiroki Tashiro, Takashi Kinoshita, Hiroshi Inoue, Keisuke Kojima, Ryo Tajiri, Koichiro Takahashi, Go Kato, Tomotaka Kawayama, Masahide Tanaka, Shinya Kimura, Hiromi Kobayashi, Masaru Uchida, Hironori Sadamatsu

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Spirometry, Male, medicine.medical_specialty, medicine.drug_class, Physical activity, physical activity, Metabolic equivalent, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Bronchodilator, Internal medicine, Forced Expiratory Volume, medicine, Humans, long-acting muscarinic antagonist, In patient, 030212 general & internal medicine, Prospective Studies, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Exercise, Lung, Aged, Original Research, COPD, medicine.diagnostic_test, business.industry, Olodaterol, General Medicine, Middle Aged, medicine.disease, Benzoxazines, Bronchodilator Agents, respiratory tract diseases, Drug Combinations, Treatment Outcome, 030228 respiratory system, chemistry, Cardiology, Female, long-acting beta 2 agonist, business, Body mass index, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25992fa836e3ce7f10cca83afc16dd00Test
http://europepmc.org/articles/PMC7501469Test

8

Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials

المؤلفون: Gary T. Ferguson, David A. Lipson, Kelly Dorais, Frank C. Sciurba, Thomas C. Corbridge, Catherine Harvey, Neil R.W. Martin, David I. Bernstein, Marjorie Stiegler, Charles Fogarty, Chang-Qing Zhu, Nicola Brown, Morrys C. Kaisermann, Chris Compton

المصدر: Respiratory Research, Vol 21, Iss 1, Pp 1-15 (2020)
Respiratory Research

مصطلحات موضوعية: Male, Budesonide, Health Status, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Budesonide, Formoterol Fumarate Drug Combination, 030212 general & internal medicine, Lung, education.field_of_study, COPD, Middle Aged, Bronchodilator Agents, Treatment Outcome, Long-acting muscarinic antagonist (LAMA), Inhaled corticosteroid (ICS), Female, Vilanterol, medicine.drug, medicine.medical_specialty, Population, Drug Administration Schedule, Fluticasone propionate, 03 medical and health sciences, Double-Blind Method, Long-acting β2-agonist (LABA), Internal medicine, Administration, Inhalation, medicine, Humans, education, Triple therapy, Aged, lcsh:RC705-779, business.industry, Research, Nebulizers and Vaporizers, Inhaler, lcsh:Diseases of the respiratory system, medicine.disease, Lung function, Androstadienes, 030228 respiratory system, chemistry, Symptoms, Formoterol, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf5859830c5c812e4b0c6afa48117cdTest
http://link.springer.com/article/10.1186/s12931-020-01360-wTest

9

Patient Characteristics and Healthcare Resource Utilization Among Patients with COPD New to LAMA/LABA Fixed-Dose Combination Treatment in US-Based Real-World Practice

المؤلفون: Deniz Guranlioglu, Bo Ding, Dan O'Brien, Lee Kallenbach, Lukas Slipski, Alan Wilk

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: β2-agonist, Male, medicine.medical_specialty, muscarinic antagonist, Fixed-dose combination, Pharmacy, disease characteristics, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, demographic characteristics, Pulmonary Disease, Chronic Obstructive, Maintenance therapy, Adrenal Cortex Hormones, Internal medicine, cost, Administration, Inhalation, medicine, Humans, Medical prescription, Adrenergic beta-2 Receptor Agonists, Original Research, Aged, Retrospective Studies, COPD, biology, business.industry, General Medicine, Lama, medicine.disease, biology.organism_classification, Bronchodilator Agents, Treatment Outcome, Female, Observational study, business, Delivery of Health Care, Cohort study

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dadaa4796e26d18651c9f4b1173e64dTest
https://doi.org/10.2147Test/copd.s238408

10

Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Improves Lung Function versus Monotherapies in GOLD Category A Patients with COPD: Pooled Data from the Phase III PINNACLE Studies

المؤلفون: Colin Reisner, Klaus F. Rabe, Martin Jenkins, Brian Lipworth, Ubaldo J. Martin, Fernando J. Martinez, Samir Arora

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Exacerbation, bronchodilator, muscarinic antagonist, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Formoterol Fumarate, Bronchodilator, β2- agonist, Multicenter Studies as Topic, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, education.field_of_study, COPD, integumentary system, co-suspension delivery technology, General Medicine, Middle Aged, Metered-dose inhaler, Obstructive lung disease, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Female, medicine.medical_specialty, medicine.drug_class, Population, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Metered Dose Inhalers, education, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, lung function, Recovery of Function, medicine.disease, Glycopyrrolate, Clinical Trials, Phase III as Topic, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168165fcd6c39542bd6a0b409b60d3ecTest
https://doi.org/10.2147Test/copd.s229794

تنقيح النتائج